메신저 리보핵산(MRNA) 제조 서비스 시장 보고서(2026년)

Messenger ribonucleic acid (mRNA) manufacturing service refers to contract-based or in-house services that produce high-quality mRNA molecules for therapeutic or vaccine purposes. These services encompass the design, synthesis, purification, and quality control of mRNA, often customized for lipid nanoparticle delivery systems. They enable the creation of safe and effective mRNA-based therapeutics and vaccines for research, clinical trials, and commercial distribution.

The core service types of messenger ribonucleic acid (mRNA) manufacturing services encompass process development, analytical testing, manufacturing, fill-finish, and other related services. Process development includes services aimed at optimizing and scaling mRNA production processes for research, clinical trials, and commercial purposes. Operational scales cover research and preclinical scale, clinical scale, and commercial scale. Applications include vaccines, therapeutics, research, and other related areas, with end users being pharmaceutical and biotechnology companies, academic and research institutions, and other relevant organizations.

Tariffs on specialized bioreactors, filtration systems, nucleic acid synthesis inputs, and cold chain logistics equipment are impacting the mrna manufacturing service market by raising setup and operating costs. Manufacturing and fill finish service segments are most exposed where imported process equipment and reagents are essential, particularly across north america and europe. Higher input costs can increase contract pricing and project budgets for clients. However, tariffs are also promoting domestic production of key materials and regional manufacturing hubs. This creates positive opportunities for local mrna service providers and equipment suppliers.

The messenger ribonucleic acid (mrna) manufacturing service market research report is one of a series of new reports from The Business Research Company that provides messenger ribonucleic acid (mrna) manufacturing service market statistics, including messenger ribonucleic acid (mrna) manufacturing service industry global market size, regional shares, competitors with a messenger ribonucleic acid (mrna) manufacturing service market share, detailed messenger ribonucleic acid (mrna) manufacturing service market segments, market trends and opportunities, and any further data you may need to thrive in the messenger ribonucleic acid (mrna) manufacturing service industry. This messenger ribonucleic acid (mrna) manufacturing service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The messenger ribonucleic acid (mrna) manufacturing service market size has grown rapidly in recent years. It will grow from $6.14 billion in 2025 to $7.12 billion in 2026 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to rise of mrna therapeutics research, vaccine emergency manufacturing demand, limited in house mrna capacity, growth of cdmo partnerships, expansion of biotech pipelines.

The messenger ribonucleic acid (mrna) manufacturing service market size is expected to see rapid growth in the next few years. It will grow to $12.97 billion in 2030 at a compound annual growth rate (CAGR) of 16.2%. The growth in the forecast period can be attributed to increase in mrna therapy trials, expansion of contract manufacturing demand, growth in personalized medicine, higher outsourcing by biotech firms, scale up of commercial mrna products. Major trends in the forecast period include integrated mrna process development services, large scale in vitro transcription production, end to end lnp encapsulation services, rapid technology transfer programs, gmp grade mrna batch manufacturing.

The growing clinical trial activity is projected to boost the messenger ribonucleic acid (mRNA) manufacturing service market in the coming period. Clinical trial activity encompasses all processes involved in planning, conducting, and managing clinical studies to assess medical interventions in humans. This activity is rising due to the adoption of digital and decentralized trial models, which allow quicker patient enrollment, remote monitoring, and more efficient data collection across larger populations. Messenger ribonucleic acid (mRNA) manufacturing services facilitate clinical trial activity by providing rapid and adaptable production of mRNA-based therapies, ensuring timely supply for various trial stages and accelerating drug development. For instance, in December 2024, the Association of the British Pharmaceutical Industry (ABPI), a UK-based trade organization, reported that the number of industry-initiated clinical trials in the UK rose to 426 in 2023, up from 411 in 2022. Therefore, the growing clinical trial activity is driving the expansion of the messenger ribonucleic acid (mRNA) manufacturing service market.

Leading companies operating in the messenger ribonucleic acid (mRNA) manufacturing service market are focusing on developing innovative solutions, such as in vitro transcription (IVT), to accelerate the production of high-quality, clinical-grade mRNA for vaccines and personalized therapies. In vitro transcription (IVT) refers to a laboratory process that synthesizes messenger RNA (mRNA) from a DNA template using RNA polymerase enzymes, enabling the production of mRNA outside of living cells for research, therapeutic, or vaccine applications. For example, in May 2025, GenScript Biotech Corporation, a China-based biotechnology company, launched a GMP-like mRNA manufacturing service to support preclinical studies and IND-enabling research. The solution provides high-purity, scalable in vitro transcription (IVT) processes with stringent control over critical quality attributes such as capping efficiency, poly(A) tail length, and impurity profiles. It supports rapid transition from preclinical to clinical stages by enabling consistent batch-to-batch production, flexible customization for different mRNA constructs, and reduced development timelines. In addition, the GMP-like framework ensures regulatory readiness through enhanced traceability, standardized workflows, and comprehensive quality documentation, helping developers de-risk later-stage manufacturing and accelerate clinical progress.

In December 2025, BioNTech SE, a Germany-based biotechnology company, acquired CureVac N.V. for an undisclosed sum. With this acquisition, BioNTech intends to reinforce its distinctive position in the mRNA sector by bringing CureVac onboard to enhance mRNA design, delivery, manufacturing, and commercialization capabilities, particularly advancing oncology initiatives such as cancer immunotherapies and BNT327. CureVac N.V. is a Germany-based company that offers mRNA development and manufacturing services for therapeutic and vaccine purposes.

Major companies operating in the messenger ribonucleic acid (mrna) manufacturing service market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Biotechnologies, Evonik Industries AG, Lonza Group AG, Charles River Laboratories International Inc., Samsung Biologics Co. Ltd., WuXi Biologics Inc., Recipharm AB, Curia Global Inc., Emergent BioSolutions Inc., AGC Biologics Inc., Corden Pharma International GmbH, Rentschler Biopharma SE, GenScript ProBio, ST Pharm Co. Ltd., etherna Immunotherapies NV, BIOMAY AG., Porton Advanced Solutions Ltd., Wacker Biotech GmbH.

North America was the largest region in the mRNA manufacturing service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the messenger ribonucleic acid (mrna) manufacturing service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the messenger ribonucleic acid (mrna) manufacturing service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The messenger ribonucleic acid (mRNA) manufacturing service market includes revenues earned by entities through the regulatory support, technology transfer, supply chain management, design and synthesis, purification, scale-up services, encapsulation services, plasmid production, quality control testing, product characterization services, formulation development, lipid nanoparticle (LNP) formulation services, and cold chain logistics services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses messenger ribonucleic acid (mrna) manufacturing service market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for messenger ribonucleic acid (mrna) manufacturing service ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The messenger ribonucleic acid (mrna) manufacturing service market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Service Type: Process Development; Analytical Testing; Manufacturing; Fill-Finish; Other Service Types
• 2) By Scale of Operation: Research And Preclinical Scale; Clinical Scale; Commercial Scale
• 3) By Application: Vaccines; Therapeutics; Research; Other Applications
• 4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Other End-Users
• Subsegments:
• 1) By Process Development: Template Design And Optimization; In Vitro Transcription Process Design; Formulation Development; Process Scale-Up And Technology Transfer; Process Validation Support
• 2) By Analytical Testing: Identity And Purity Testing; Potency And Functional Assays; Impurity And Contaminant Analysis; Stability And Shelf Life Studies; Quality Control Release Testing
• 3) By Manufacturing: Plasmid Deoxyribonucleic Acid Production; In Vitro Transcription Manufacturing; Enzymatic Capping And Tailoring; Purification And Concentration; Large-Scale Batch Production
• 4) By Fill-Finish: Aseptic Filling Services; Vial And Syringe Filling; Lyophilization Services; Labeling And Packaging; Cold Chain Handling And Storage
• 5) By Other Service Types: Regulatory Support Services; Quality Assurance And Documentation; Supply Chain And Logistics Support; Technology Consulting Services; Custom Manufacturing Solutions
• Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; FUJIFILM Biotechnologies; Evonik Industries AG; Lonza Group AG; Charles River Laboratories International Inc.; Samsung Biologics Co. Ltd.; WuXi Biologics Inc.; Recipharm AB; Curia Global Inc.; Emergent BioSolutions Inc.; AGC Biologics Inc.; Corden Pharma International GmbH; Rentschler Biopharma SE; GenScript ProBio; ST Pharm Co. Ltd.; etherna Immunotherapies NV; BIOMAY AG.; Porton Advanced Solutions Ltd.; Wacker Biotech GmbH.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Artificial Intelligence & Autonomous Intelligence
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Integrated Mrna Process Development Services
  • 4.2.2 Large Scale In Vitro Transcription Production
  • 4.2.3 End To End Lnp Encapsulation Services
  • 4.2.4 Rapid Technology Transfer Programs
  • 4.2.5 Gmp Grade Mrna Batch Manufacturing

5. Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Companies
• 5.2 Biotechnology Companies
• 5.3 Academic And Research Institutes
• 5.4 Vaccine Developers
• 5.5 Gene Therapy Developers

6. Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Segmentation

• 9.1. Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Process Development, Analytical Testing, Manufacturing, Fill-Finish, Other Service Types
• 9.2. Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Scale of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Research And Preclinical Scale, Clinical Scale, Commercial Scale
• 9.3. Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Vaccines, Therapeutics, Research, Other Applications
• 9.4. Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Other End-Users
• 9.5. Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Sub-Segmentation Of Process Development, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Template Design And Optimization, In Vitro Transcription Process Design, Formulation Development, Process Scale-Up And Technology Transfer, Process Validation Support
• 9.6. Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Sub-Segmentation Of Analytical Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Identity And Purity Testing, Potency And Functional Assays, Impurity And Contaminant Analysis, Stability And Shelf Life Studies, Quality Control Release Testing
• 9.7. Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Sub-Segmentation Of Manufacturing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Plasmid Deoxyribonucleic Acid Production, In Vitro Transcription Manufacturing, Enzymatic Capping And Tailoring, Purification And Concentration, Large-Scale Batch Production
• 9.8. Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Sub-Segmentation Of Fill-Finish, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Aseptic Filling Services, Vial And Syringe Filling, Lyophilization Services, Labeling And Packaging, Cold Chain Handling And Storage
• 9.9. Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Sub-Segmentation Of Other Service Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Regulatory Support Services, Quality Assurance And Documentation, Supply Chain And Logistics Support, Technology Consulting Services, Custom Manufacturing Solutions

10. Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Regional And Country Analysis

• 10.1. Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 11.1. Asia-Pacific Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 12.1. China Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 13.1. India Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 14.1. Japan Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 15.1. Australia Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 16.1. Indonesia Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 17.1. South Korea Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 18.1. Taiwan Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 19.1. South East Asia Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 20.1. Western Europe Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 21.1. UK Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 22.1. Germany Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 23.1. France Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 24.1. Italy Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 25.1. Spain Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 26.1. Eastern Europe Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 27.1. Russia Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 28.1. North America Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 29.1. USA Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 30.1. Canada Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 31.1. South America Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 32.1. Brazil Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 33.1. Middle East Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

• 34.1. Africa Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market, Segmentation By Service Type, Segmentation By Scale of Operation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Regulatory and Investment Landscape

36. Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Competitive Landscape And Company Profiles

• 36.1. Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. FUJIFILM Biotechnologies Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

37. Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Other Major And Innovative Companies

• Charles River Laboratories International Inc., Samsung Biologics Co. Ltd., WuXi Biologics Inc., Recipharm AB, Curia Global Inc., Emergent BioSolutions Inc., AGC Biologics Inc., Corden Pharma International GmbH, Rentschler Biopharma SE, GenScript ProBio, ST Pharm Co. Ltd., etherna Immunotherapies NV, BIOMAY AG., Porton Advanced Solutions Ltd., Wacker Biotech GmbH

38. Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market

41. Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market High Potential Countries, Segments and Strategies

• 41.1 Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer